Literature DB >> 32101645

Pulmonary rehabilitation in interstitial lung diseases: A review of the literature.

Krzysztof Wytrychowski1, Anna Hans-Wytrychowska2, Paweł Piesiak3, Marta Majewska-Pulsakowska4, Krystyna Rożek-Piechura5.   

Abstract

There are more than 200 different diseases classed as interstitial lung diseases (ILDs). For epidemiological and practical purposes, ILDs are classified into diseases of known and unknown etiology. The aim of this review is to evaluate our current knowledge about the efficacy and safety of pulmonary rehabilitation (PR) in patients with ILDs. Other issues, such as ILD pathogenesis, prevalence and comorbidity, are also elaborated in the review. Pulmonary rehabilitation is an important part of comprehensive care for patients with ILDs. In comparison to PR for patients with chronic pulmonary obstructive disease (COPD), the number of clinical studies concerning PR for patients with ILDs is small. The majority of trials have been performed in relatively small groups of patients. The principles of PR in this group of patients are the same as for patients with COPD. Exercise-induced desaturation is frequently observed during PR, which is the main source of complications in patients with ILDs. Major differences between ILD and COPD patients include poorer exercise tolerance and faster development of respiratory failure in patients with ILDs.

Entities:  

Keywords:  airway management; interstitial lung diseases; pulmonary rehabilitation

Year:  2020        PMID: 32101645     DOI: 10.17219/acem/115238

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  4 in total

1.  The benefits of pulmonary rehabilitation in patients with COVID-19.

Authors:  Zhen-Feng He; Nan-Shan Zhong; Wei-Jie Guan
Journal:  ERJ Open Res       Date:  2021-05-31

2.  Comparison of heart rates at fixed percentages and the ventilatory thresholds in patients with interstitial lung disease.

Authors:  Karin Vonbank; Antje Lehmann; Dominik Bernitzky; Maximilian Robert Gysan; Stefan Simon; Pavla Krotka; Ralf-Harun Zwick; Marco Idzko; Martin Burtscher
Journal:  Scand J Med Sci Sports       Date:  2021-12-26       Impact factor: 4.645

3.  Anti-MDA5 Amyopathic Dermatomyositis-A Diagnostic and Therapeutic Challenge.

Authors:  Anca Bobirca; Cristina Alexandru; Anca Emanuela Musetescu; Florin Bobirca; Anca Teodora Florescu; Magdalena Constantin; Tiberiu Tebeica; Alesandra Florescu; Sebastian Isac; Mihai Bojinca; Ioan Ancuta
Journal:  Life (Basel)       Date:  2022-07-23

4.  Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study.

Authors:  Kai Liu; Weitong Zhang; Yadong Yang; Jinpeng Zhang; Yunqian Li; Ying Chen
Journal:  Complement Ther Clin Pract       Date:  2020-04-01       Impact factor: 2.446

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.